Elanco Animal Health Incorporated
ELAN
Peringkat dalam Saham
#1871
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Harga Saham
$22.70
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$11.34B
Perubahan (1 hari)
-3.45%
Perubahan (1 tahun)
4.97%
Negara
US
Perdagangan Elanco Animal Health Incorporated (ELAN)
Kategori
Healthcare
Rasio P/E untuk Elanco Animal Health Incorporated (ELAN)
Rasio P/E per October 2026 TTM: -55.00
Menurut laporan keuangan dan harga saham terbaru dari Elanco Animal Health Incorporated, rasio P/E saat ini (TTM) adalah -55.00. Pada akhir 2023, perusahaan memiliki rasio P/E sebesar -5.96.
Riwayat rasio P/E untuk Elanco Animal Health Incorporated dari 2015 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | -55.00 | -410.73% |
| 2024 | 17.70 | -397.03% |
| 2023 | -5.96 | -92.21% |
| 2022 | -76.50 | 167.23% |
| 2021 | -28.63 | 18.44% |
| 2020 | -24.17 | -115.10% |
| 2019 | 160.04 | 39.96% |
| 2018 | 114.35 | -377.06% |
| 2017 | -41.27 | -84.58% |
| 2016 | -267.71 | 340.08% |
| 2015 | -60.83 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | -163.56% |
IN
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.